D89.835
Cytokine release syndrome, grade 5
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytokine Release Syndrome (CRS) is a serious medical condition that occurs when the immune system releases a large amount of cytokines into the bloodstream. This overproduction can cause widespread inflammation and organ damage. When CRS reaches a critical severity classified as grade 5, it indicates a life-threatening situation requiring immediate medical intervention. This document provides an overview of CRS grade 5, including potential causes, symptoms, diagnosis, and general management approaches.
Causes & Symptoms
Clinical Causes: Immunotherapies, such as CAR T-cell therapy, which activate the immune system intensely Certain infections, notably viral infections like COVID-19 Malignancies that provoke immune overactivation Use of immune-boosting medications or treatments that trigger excessive cytokine release
Key Symptoms: Severe fever with a rapid onset Extreme fatigue and weakness Swelling and inflammation, often in the face, arms, or legs Shortness of breath and difficulty breathing Low blood pressure, leading to dizziness or fainting Rapid heartbeat Confusion or altered mental state Organ dysfunctions, including liver or kidney failure
Diagnostic & Treatment
Diagnosis Path: Diagnosing grade 5 CRS involves a combination of clinical evaluation and laboratory tests. Medical professionals look for signs of severe systemic inflammation, organ impairment, and abnormal cytokine levels. Blood tests may reveal elevated levels of cytokines like IL-6, cytokine panels, and markers of organ dysfunction. Imaging studies may be performed to assess organ status. Since CRS grade 5 is life-threatening, immediate hospitalization and intensive monitoring are essential for diagnosis and management.
Treatment Protocols: Supportive therapies such as intravenous fluids and oxygen therapy Use of medications to block cytokine activity, like IL-6 receptor antagonists (e.g., tocilizumab) Organ support treatments, including dialysis or mechanical ventilation as needed Administration of corticosteroids to suppress immune hyperactivity Close monitoring of vital signs, organ function, and cytokine levels Addressing and treating any underlying causes, such as infections or underlying malignancies
Clinical Advice & FAQs
Billing Guidance
Is D89.835 a billable ICD-10 code?
Yes, D89.835 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.835?
Clinical documentation must specify the nature of Cytokine release syndrome, grade 5 and any associated comorbidities for accurate reporting.
Cite this Clinical Reference